The doctor who proved less cannabis works better than more
Cannabis microdosing and the sensitization protocol: clinical dosing framework
Bottom Line
Many medical cannabis patients get better results from ultra-low doses (1-5mg THC) than from higher doses, and a 6-day sensitization protocol can reset tolerance and dramatically reduce consumption while maintaining therapeutic benefit.
Why It Matters
This framework challenged the recreational cannabis culture's assumption that more is better and gave medical patients and clinicians a practical, evidence-informed protocol for finding the lowest effective dose. The sensitization protocol has been adopted by medical cannabis practices worldwide.
The Backstory
Every cannabis dispensary in America is designed to sell you more. Higher THC percentages command higher prices. Bigger packages offer better value. Concentrate products deliver more milligrams per dollar. The entire market infrastructure assumes that more cannabis equals more benefit.
Dustin Sulak, an osteopathic physician in Maine who has treated over 18,000 medical cannabis patients, discovered that the opposite is usually true. Most of his patients were using far more cannabis than they needed. When he guided them to find their minimum effective dose — often as low as 1-5 milligrams of THC — many found better symptom relief, fewer side effects, less tolerance buildup, and a dramatically lower consumption rate.
His 6-day sensitization protocol, developed through years of clinical practice and formalized in the Handbook of Cannabis for Clinicians, has become the most widely adopted dosing framework in medical cannabis. Its central insight is counterintuitive: the optimal dose is usually the smallest one that works.
The Clinician
Dustin Sulak did not start as a cannabis specialist. He earned his undergraduate degrees in nutrition science and biology from Indiana University, his DO from the Arizona College of Osteopathic Medicine, and completed his internship at Maine-Dartmouth Family Medicine Residency. He trained in osteopathic manipulation, cranial therapy, and integrative medicine — a background in listening to patients and their bodies rather than reaching for the prescription pad first.
When Maine legalized medical cannabis, Sulak founded Integr8 Health and began seeing patients who were self-medicating with cannabis — often in doses that would make a pharmacologist wince. Patients came in using 100mg, 200mg, even 300mg of THC per day and reporting that it had stopped working. Tolerance had consumed the therapeutic benefit.
The observation that changed his practice was simple: when these same patients took a short break and restarted at a fraction of their previous dose, the cannabis worked again — often better than before. The question was whether this could be systematized.
Over the next several years, treating more than 18,000 patients, Sulak developed and refined the sensitization protocol. He now serves on the board of directors of the Society of Cannabis Clinicians, lectures internationally on cannabis dosing, and co-founded Healer, a medical cannabis patient education platform. His Handbook of Cannabis for Clinicians (W.W. Norton, 2021) has become a standard reference for physicians entering the field.
The Pharmacological Foundation
Sulak's protocol is not built on intuition. It rests on established pharmacology that other pillar studies in this collection document.
The Sensitization Protocol
Sulak's protocol is a 6-day process designed to reset cannabis tolerance and identify the minimum effective dose. It has been completed by thousands of patients under clinical supervision.
The Numbers
Up to 60%
reduction in cannabis consumption reported by patients who complete the sensitization protocol, while maintaining or improving therapeutic benefit. For a patient previously using 50mg of THC per day, this might mean finding their optimal dose is 15-20mg — with better symptom relief and fewer side effects at the lower dose.
For context, the average recreational edible in the United States contains 10mg THC per serving. A therapeutic micro-dose (1-5mg) is half or less. Many patients find that a fraction of one standard edible serving provides more relief than the multiple servings they were previously consuming.
Sulak clinical practice, Integr8 Health
Why This Matters Beyond Medicine
The implications extend beyond medical cannabis patients. Daily recreational users who find that cannabis has stopped working — or that they need increasing amounts to achieve the same effect — are experiencing the same receptor downregulation that Sulak's protocol addresses.
The tolerance break is already folk wisdom in cannabis culture. Sulak's contribution is systematizing it: defining the minimum abstinence period, providing a structured reintroduction protocol, and establishing the minimum effective dose principle that prevents the tolerance cycle from restarting.
The biphasic dose-response is the pharmacological foundation. Crippa showed that low-dose THC reduces anxiety while high-dose THC increases it. Childs showed that 7.5mg THC reduced stress while 12.5mg made it worse. The therapeutic window is narrow, and most people — especially those in high-tolerance states — are shooting past it.
Myth vs. Reality
Higher THC percentages and bigger doses mean better therapeutic results.
Published research and extensive clinical experience show the opposite. Cannabis has a biphasic dose-response: therapeutic benefits often peak at low-to-moderate doses and decline at higher doses, while side effects continue to increase. A University of Chicago trial found that 7.5mg THC reduced stress while 12.5mg THC increased it. Clinical practice with 18,000+ patients shows that most people achieve better outcomes at doses far below what recreational culture normalizes.
The Evidence
Childs et al. (2017): 7.5mg vs 12.5mg THC, n=42. Crippa et al. (2009): biphasic anxiety dose-response. Bhaskar et al. (2021): Delphi consensus recommends starting at 2.5mg THC for chronic pain.
Childs et al. (2017); Sulak clinical practice; Bhaskar et al. (2021)
Cannabis microdosing and the sensitization protocol: clinical dosing framework
Sulak D () · Handbook of Cannabis for Clinicians: Principles and Practice (W.W. Norton)
Cite this study
Sulak, Dustin. (2019). Cannabis microdosing and the sensitization protocol: clinical dosing framework. Clinical practice / Handbook of Cannabis for Clinicians (W.W. Norton).